The Impact of concurrent (aerobic-resistance) training on prostate cancer

The Impact of concurrent (aerobic-resistance) training on serum levels of IGF-I and IGFBP-3 in men with prostate cancer

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT20180624040222N1

Enrollment

Registered

2018-11-11

Start date

2018-04-09

Completion date

Unknown

Last updated

2019-01-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Prostate cancer. Carcinoma in situ of prostate

Interventions

Intervention 1: Intervention group: Intervention group with practice protocol contain a concurrent training course ( aerobic-resistance ) that designed by the researcher( according to the American Co

Eligibility

Sex/Gender

Male

Age

50 Years to 75 Years

Inclusion criteria

Inclusion criteria: Subjects are putted at the stage T1 and T2 of the disease . Physical health based on a medical history questionnaire that has no history of disease. No participation in any exercise program atlast 2 month before take part in exercise training program. Subjects get allowed to enter the project after a cardiovascular examination, blood pressure measurement and ECG monitoring by a specialist. Take the physical activities readiness questionnaire ( PAR-Q) and The informed consent form for participation in this research by subjects.

Exclusion criteria

Exclusion criteria: Having of heart or lung disease. Having high blood pressure. Having diabetes Having renal disease smoking

Design outcomes

Primary

Measure	Time frame
Phosphatase and tensin homolog (PTEN). Timepoint: Before the intervention (Before the 8 week concurrent (aerobic-resistance) training) and the end intervention(after the 8 week concurrent (aerobic-resistance) training). Method of measurement: Blood samples will be collected 24 hours before the training starts and 48 hours after the last exercise session.;Insulin-like growth factor 1 (IGF-1). Timepoint: Before the intervention (Before the 8 week concurrent (aerobic-resistance) training) and the end intervention(after the 8 week concurrent (aerobic-resistance) training). Method of measurement: Blood samples will be collected 24 hours before the training starts and 48 hours after the last exercise session.;Insulin-like growth factor-binding protein 3. Timepoint: Before the intervention (Before the 8 week concurrent (aerobic-resistance) training) and the end intervention(after the 8 week concurrent (aerobic-resistance) training). Method of measurement: Blood samples will be collected 24 hours before the training starts and 48 hours after the last exercise session.;Sex hormone-binding globulin (SHBG). Timepoint: Before the intervention (Before the 8 week concurrent (aerobic-resistance) training) and the end intervention(after the 8 week concurrent (aerobic-resistance) training). Method of measurement: Blood samples will be collected 24 hours before the training starts and 48 hours after the last exercise session.;Aerobic capacity. Timepoint: Before the intervention (Before the 8 week concurrent (aerobic-resistance) training) and the end intervention(after the 8 week concurrent (aerobic-resistance) training). Method of measurement: To estimate the maximum oxygen consumption, the Modified Bruce test on the treadmill [ based on the maximum oxygen consumption equation: 8.545 +(test run time × 2.282).	—

Measure

Time frame

Phosphatase and tensin homolog (PTEN). Timepoint: Before the intervention (Before the 8 week concurrent (aerobic-resistance) training) and the end intervention(after the 8 week concurrent (aerobic-resistance) training). Method of measurement: Blood samples will be collected 24 hours before the training starts and 48 hours after the last exercise session.;Insulin-like growth factor 1 (IGF-1). Timepoint: Before the intervention (Before the 8 week concurrent (aerobic-resistance) training) and the end intervention(after the 8 week concurrent (aerobic-resistance) training). Method of measurement: Blood samples will be collected 24 hours before the training starts and 48 hours after the last exercise session.;Insulin-like growth factor-binding protein 3. Timepoint: Before the intervention (Before the 8 week concurrent (aerobic-resistance) training) and the end intervention(after the 8 week concurrent (aerobic-resistance) training). Method of measurement: Blood samples will be collected 24 hours before the training starts and 48 hours after the last exercise session.;Sex hormone-binding globulin (SHBG). Timepoint: Before the intervention (Before the 8 week concurrent (aerobic-resistance) training) and the end intervention(after the 8 week concurrent (aerobic-resistance) training). Method of measurement: Blood samples will be collected 24 hours before the training starts and 48 hours after the last exercise session.;Aerobic capacity. Timepoint: Before the intervention (Before the 8 week concurrent (aerobic-resistance) training) and the end intervention(after the 8 week concurrent (aerobic-resistance) training). Method of measurement: To estimate the maximum oxygen consumption, the Modified Bruce test on the treadmill [ based on the maximum oxygen consumption equation: 8.545 +(test run time × 2.282).

—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactAlireza Ghadian

Bagheiat-allah University of Medical Sciences

P_Ghdian@yahoo.com+98 21 8805 0435

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026